NM

Nisha Maheshwari

Active Director Director DIN 08228976
DIN 08228976 First appointment Sep 2018 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2018
Shareholding value •••• Premium profile

About Nisha Maheshwari

Data last updated:

Nisha Maheshwari is a Director at Consollate Pharma Private Limited (since 2018). The company operates in Trading. Consollate Pharma Private Limited reported revenue of ₹49.7 Lakh (FY 2025).

DIN 08228976
Primary Designation Director
Industry Trading
First Appointment 20 Sep 2018
Oldest Company Age 8 yrs
Largest company Consollate Pharma Private Limited · ₹49.7 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Consollate Pharma Private Limited U51909RJ2018PTC061877
Director20 Sep 20182018₹49.7 Lakh (FY 2025)Active

Board colleagues of Nisha Maheshwari

Directorship timeline

Open interactive timeline →
Consollate Pharma Private Limited
Premium access

Shareholding and investment profile for Nisha Maheshwari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nisha Maheshwari

Nisha Maheshwari currently holds 1 directorship: Consollate Pharma Private Limited (Director, since 20 Sep 2018, revenue ₹49.7 Lakh (FY 2025)).

Nisha Maheshwari was first appointed on 20 Sep 2018 as Director at Consollate Pharma Private Limited.

The current boards of Nisha Maheshwari's companies include Chanchal Maheshwari (Consollate Pharma Private Limited), Seema (Consollate Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available